Movement Priming for Stroke Recovery
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to to determine the effect of movement-based priming using the upper limbs on lower limb neuroplasticity and behaviors in chronic stroke. The main questions we aim to answer are: 1. What are the acute effect of UL-priming on lower limb neuroplasticity and motor behaviors in persons with stroke compared to other priming modalities? 2. What are the time effects of UL-priming on neuroplasticity and motor behavior in individuals with stroke? In this cross over study, participants will be involved in three priming sessions involving - UL-priming using rhythmic, symmetric, bilateral priming involving the movement of at least one major joint in the upper limbs. AND - Sham priming using auditory stimulation (1 Hz metronome). AND - Lower-limb movement-based priming using rhythmic, symmetric, dorsiflexion and plantarflexion movements. Researchers will compare outcome measures between the different priming sessions.
Will I have to stop taking my current medications?
The trial requires that participants do not use anti-spasticity medications and medications that could alter brain activity or increase seizure risk, like antidepressants, antipsychotics, anxiolytics, and anticonvulsants.
What data supports the effectiveness of the treatment Movement Priming for Stroke Recovery?
Research shows that bilateral motor priming, which involves using both sides of the body, can help improve motor function in stroke patients. Studies have found that this type of priming, when combined with specific training, can enhance recovery of the affected limb and improve overall motor performance.12345
Is movement priming safe for humans?
Movement priming techniques, including those involving the lower and upper limbs, have been studied in stroke rehabilitation and are generally considered safe for humans. However, most techniques are still primarily used in research settings and may not be widely available in clinical practice.23456
How is the Movement Priming for Stroke Recovery treatment different from other treatments?
This treatment is unique because it uses movement priming, which involves specific exercises or stimuli to prepare the brain for rehabilitation, potentially enhancing neuroplasticity (the brain's ability to reorganize itself) and improving motor recovery after a stroke. It includes various forms like lower limb-based, upper limb-based, and stimulation-based priming, which are cost-effective and can be integrated with other therapies to optimize recovery.12346
Research Team
Sangeetha Madhavan, PT, PhD
Principal Investigator
University of Illinois at Chicago
Eligibility Criteria
This trial is for individuals who have had a single stroke affecting one side of the brain at least 6 months ago and are experiencing walking difficulties. They must be able to perform certain arm movements and not be taking specific medications that affect the brain's activity or increase seizure risk. People with severe cognitive impairment, other neurological disorders, uncontrolled medical conditions, or those who can't follow instructions due to language barriers cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Priming Sessions
Participants undergo three priming sessions: UL-priming, sham priming, and LL-priming
Immediate Follow-up
Participants are assessed for changes in muscle strength and corticomotor excitability immediately after each priming session
Short-term Follow-up
Participants are monitored for changes in muscle strength and gait speed at 30 and 60 minutes after priming
Long-term Follow-up
Participants are assessed for changes in muscle strength and corticomotor excitability 24 hours after priming
Treatment Details
Interventions
- Lower limb-based movement priming (LL-priming)
- Sham priming
- Stimulation-based priming (Stim priming)
- Upper limb-based movement priming (UL-priming)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor